UBS downgrades Pfizer, cites lower Covid expectations and a slow pipeline
[ad_1]
Pfizer shares are down more than 12% this year on expectations that number and severity of Covid cases will stabilize.
[ad_2]
Source link
[ad_1]
Pfizer shares are down more than 12% this year on expectations that number and severity of Covid cases will stabilize.
[ad_2]
Source link